ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 47

Analysis of the Role of RORγt+Foxp3+ T Regulatory 17 (Tr17) Cells in Murine Autoimmune Arthritis Model

Kotona Furuyama1, Yuya Kondo1, Masaru Shimizu2, Iizuka Akira1, Masahiro Yokosawa1, Seiji Segawa1, Hiroto Tsuboi1, Isao Matsumoto1 and Takayuki Sumida1, 1Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 2Internal Medicine, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: animal models and transcription factor, cytokines, rheumatoid arthritis, T-Regulatory Cells

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Title: Rheumatoid Arthritis – Animal Models Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: RORγt+Foxp3+ regulatory T (Treg) cells, designated as Tr17 is one of the new subset of Treg cells, having the potential to regulate the development of experimental autoimmune encephalomyelitis (EAE) thorough a specific repression of Th17 mediated inflammation. The function of Tr17 remain unclear in the development of other autoimmune diseases such as collagen induced arthritis (CIA)./To clarify the role of RORγt+Foxp3+ Tr17 in the development CIA.

Methods: 1) Lymphocytes in draining lymph node were harvested from C57BL/6 mice on 10 days after immunization of type II collagen (CII) emulsified with complete Freund’s adjuvant. The expression of RORγt in Foxp3+Treg cells was analyzed by flow cytometry and compared them with lymphocytes of non-immunized mice. 2) At 10 days after CII immunization, C-C chemokine receptor type 6 (CCR6), CD25, cytotoxic T-lymphocyte antigen 4 (CTLA-4), and Glucocorticoid-induced TNF-receptor (GITR) expression on Tr17, RORγt–Treg cells, and RORγt+ T cells (Th17) in lymph node were analyzed by flow cytometry. 3) Lymphocytes in draining lymph node were harvested from Foxp3IRES-gfp reporter mice on 10 days after first CII immunization. CD4+GFP+ Treg and CD4+GFP– T cells were isolated and stimulated with PMA and Ionomycin in vitro. The expression of IL-10 and IL-17 in RORγt+GFP+ Tr17 cells was analyzed by flow cytometry and compared with that in RORγt–GFP+ cells or RORγt+GFP– cells. 4) After the induction of CIA, lymphocytes in inflamed ankle joints and draining lymph node were harvested from Foxp3IRES-gfp reporter mice. The expression of CCR6, CD25, and CTLA-4 were analyzed in RORγt+GFP+ cells, RORγt–GFP+ cells or RORγt+GFP– cells by flow cytometry.

Results: 1) RORγt+Foxp3+ Tr17 cells in draining lymph nodes were significantly increased in CII-immunized mice compared with non-immunized mice. 2) CCR6 and CD25 expression was elevated on Tr17 cells compared with RORγt–Treg cells and Th17 cells and CTLA-4 and GITR expression was also up-regulated on Tr17 cells compared with RORγt–Treg cells. 3) IL-10 producing cells were increased in Tr17 cells compared with RORγt–Treg cells (33.2 +/- 2.95, p < 0.001). On the other hand, IL-17 producing cells were decreased in Tr17 cells in spite of the high expression of RORγt compared with RORγt+Th17 cells (9.57 +/- 1.25, p = 0.002) (Figure). 4) CCR6+Treg cells were increased in inflamed ankle joints compared with draining lymph node after the induction of CIA. CD25 expression was elevated on joint infiltrating CCR6+Treg cells compare with CCR6–Treg cells. There was no difference of CTLA-4 expression between CCR6+ and CCR6–Treg cells in inflamed joints.

Conclusion: Tr17 cells were increased in the course of CIA and might preferentially infiltrated into inflamed joints. Moreover, Tr17 cells had the potential to regulate the development of CIA thorough the high expression of suppressive molecules such as IL-10 and CTLA-4 in inflamed joints.


Disclosure: K. Furuyama, None; Y. Kondo, None; M. Shimizu, None; I. Akira, None; M. Yokosawa, None; S. Segawa, None; H. Tsuboi, None; I. Matsumoto, None; T. Sumida, None.

To cite this abstract in AMA style:

Furuyama K, Kondo Y, Shimizu M, Akira I, Yokosawa M, Segawa S, Tsuboi H, Matsumoto I, Sumida T. Analysis of the Role of RORγt+Foxp3+ T Regulatory 17 (Tr17) Cells in Murine Autoimmune Arthritis Model [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/analysis-of-the-role-of-ror%ce%b3tfoxp3-t-regulatory-17-tr17-cells-in-murine-autoimmune-arthritis-model/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/analysis-of-the-role-of-ror%ce%b3tfoxp3-t-regulatory-17-tr17-cells-in-murine-autoimmune-arthritis-model/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology